Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5XEZ1

Entry ID Method Resolution Chain Position Source
AF-Q5XEZ1-F1 Predicted AlphaFoldDB

48 variants for Q5XEZ1

Variant ID(s) Position Change Description Diseaes Association Provenance
tmp_2_10774102_A_T 19 S>T No 1000Genomes
ENSVATH00246515 21 F>S No 1000Genomes
tmp_2_10774052_G_T 35 F>L No 1000Genomes
ENSVATH01892388 59 N>T No 1000Genomes
tmp_2_10773750_G_A 69 P>L No 1000Genomes
ENSVATH01892381 71 V>F No 1000Genomes
ENSVATH00246514 76 D>E No 1000Genomes
tmp_2_10773715_G_C 81 L>V No 1000Genomes
ENSVATH01892378 85 D>Y No 1000Genomes
ENSVATH05587693 88 R>K No 1000Genomes
tmp_2_10773597_C_T 91 V>I No 1000Genomes
ENSVATH01892377 106 L>F No 1000Genomes
ENSVATH01892374 109 L>S No 1000Genomes
ENSVATH01892372 110 K>R No 1000Genomes
tmp_2_10773530_G_A 113 S>L No 1000Genomes
ENSVATH14550594 114 S>T No 1000Genomes
ENSVATH05587692 125 V>L No 1000Genomes
ENSVATH00246513 141 S>T No 1000Genomes
ENSVATH01892367 142 Y>* No 1000Genomes
ENSVATH01892368 142 Y>C No 1000Genomes
ENSVATH05587690 146 G>V No 1000Genomes
ENSVATH05587689 147 D>Y No 1000Genomes
ENSVATH14550592 164 G>A No 1000Genomes
ENSVATH01892359 164 G>S No 1000Genomes
ENSVATH01892349 188 L>F No 1000Genomes
ENSVATH05587682 192 N>S No 1000Genomes
ENSVATH13396734 198 E>D No 1000Genomes
ENSVATH01892337 201 A>P No 1000Genomes
ENSVATH05587679 216 D>E No 1000Genomes
ENSVATH13396732 225 D>N No 1000Genomes
tmp_2_10772850_A_C 229 L>V No 1000Genomes
tmp_2_10772844_G_T 231 L>I No 1000Genomes
ENSVATH01892335 247 A>S No 1000Genomes
tmp_2_10772628_G_T 259 A>D No 1000Genomes
tmp_2_10772629_C_T 259 A>T No 1000Genomes
ENSVATH01892332 264 K>Q No 1000Genomes
ENSVATH01892330 268 P>A No 1000Genomes
ENSVATH01892330 268 P>S No 1000Genomes
ENSVATH05587674 277 K>N No 1000Genomes
ENSVATH05587668 289 I>R No 1000Genomes
tmp_2_10772288_G_C 290 L>V No 1000Genomes
ENSVATH05587666 291 S>Y No 1000Genomes
tmp_2_10772258_T_C 300 I>V No 1000Genomes
ENSVATH00246502 323 Q>H No 1000Genomes
ENSVATH05587662 327 I>L No 1000Genomes
ENSVATH05587661 327 I>T No 1000Genomes
ENSVATH13396730 337 I>S No 1000Genomes
tmp_2_10772023_G_C 339 Q>E No 1000Genomes

No associated diseases with Q5XEZ1

1 regional properties for Q5XEZ1

Type Name Position InterPro Accession
domain GPCR, rhodopsin-like, 7TM 53 - 309 IPR017452

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus membrane ; Single-pass type II membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

4 GO annotations of molecular function

Name Definition
galactosyltransferase activity Catalysis of the transfer of a galactosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
glycosyltransferase activity Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).
hydroxyproline O-galactosyltransferase activity Catalysis of the transfer of galactose from UDP-galactose to hydroxyproline residues present in the peptide backbone.
UDP-glycosyltransferase activity Catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule.

2 GO annotations of biological process

Name Definition
arabinogalactan protein metabolic process The chemical reactions and pathways involving a cell wall arabinogalactan II glycoprotein, which is composed of a group of core protein of highly varying length and domain complexity. These are O-glycosylated at one or more hydroxyproline residues by arabinogalactan (AG) type II groups, which consist of (1->3)-beta-galactan and (1->6)-beta-linked galactan chains connected to each other by (1->3,1->6)-linked branch points, O-3 and O-6 positions substituted with terminal arabinosyl residues. Also, rhamnose, fucose, glucuronic and galacturonic acid can be present in the glycan structures.
protein O-linked glycosylation via hydroxyproline The glycosylation of proteins via 04 atom of hydroxyproline to form O4-glycosyl-L-hydroxyproline; the most common form is arabinofuranosyl-4-proline.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8BG28 B3galnt2 UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 Mus musculus (Mouse) PR
Q8RX55 GALT5 Hydroxyproline O-galactosyltransferase GALT5 Arabidopsis thaliana (Mouse-ear cress) PR
Q8GXG6 GALT4 Hydroxyproline O-galactosyltransferase GALT4 Arabidopsis thaliana (Mouse-ear cress) PR
Q8L7F9 GALT1 Beta-1,3-galactosyltransferase GALT1 Arabidopsis thaliana (Mouse-ear cress) PR
Q94F27 HPTG1 Hydroxyproline O-galactosyltransferase HPGT1 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LV16 GALT6 Hydroxyproline O-galactosyltransferase GALT6 Arabidopsis thaliana (Mouse-ear cress) PR
A7XDQ9 GALT2 Hydroxyproline O-galactosyltransferase GALT2 Arabidopsis thaliana (Mouse-ear cress) PR
Q9ASW1 GALT3 Hydroxyproline O-galactosyltransferase GALT3 Arabidopsis thaliana (Mouse-ear cress) PR
Q6P3P5 b3gnt5 Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MESLPTTVPS KSERRARSSK FSQSSSKPSV IMAFFSCVAW LYVAGRLWQD AENRVVLNNI
70 80 90 100 110 120
LKKSYDQKPK VLTVDDKLMV LGCKDLERRI VETEMELTLA KSQGYLKNLK SGSSSGKKLL
130 140 150 160 170 180
AVIGVYSGFG SHLRRNTFRG SYMPQGDALR KLEERGIVIR FVIGRSPNRG DSLDRKIDEE
190 200 210 220 230 240
NQARKDFLIL ENHEEAQEEL AKKVKFFFSA AVQNWDAEFY IKVDDNIDLD LEGLIGLLES
250 260 270 280 290 300
RRGQDAAYIG CMKSGEVVAE EGGKWYEPEW WKFGDEKSYF RHAAGSLLIL SKTLAQYVNI
310 320 330 340
NSGSLKTYAF DDTSIGSWMI GVQATYIDDN RLCCSSIRQD KVCSVA